Ian Clements, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ian Clements, Ph.D.
Earlier roles on record: CFO at Mirum Pharmaceuticals, Inc. (MIRM) until May 15, 2023. Mirum Pharmaceuticals, Inc. reported in an 8-K filed January 9, 2023 that Ian Clements, Ph.D. resigned as Chief Financial Officer, effective May 15, 2023.
“On January 7, 2023, the Company and Ian Clements, Ph.D. entered into a Transition, Separation and Consulting Agreement, dated January 7, 2023 (the “Agreement”), pursuant to which Dr. Clements will resign as Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-10–2023-05-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.